$DBVT

DBV Technologies S.A.

Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Chatillon

DBVT chart

What traders are saying about $DBVT

Latest posts

DBV Technologies S.A. news

DBV Technologies S.A. key financials

USD2025202420232022
Revenue$5.6M$4.2M$15.7M$4.8M
Net income-$146.9M-$113.9M-$72.7M$96.3M
Diluted EPS$-1.05$-1.17$-0.76$-1.24
Total assets (year end)$233.7M$65.7M$183.0M$246.5M
Cash and equivalents (year end)$194.2M$32.5M$141.4M$209.2M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About DBV Technologies S.A.

Ticker
DBVT (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Chatillon
Incorporated in
France
Fiscal year end
December 31
SEC CIK
1613780

Frequently asked questions

What exchange is DBV Technologies S.A. listed on?

DBV Technologies S.A. trades on the Nasdaq under the ticker symbol DBVT.

What industry is DBV Technologies S.A. in?

DBV Technologies S.A. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.

Where is DBV Technologies S.A. headquartered?

DBV Technologies S.A.'s business address on file with the SEC is in Chatillon.

When does DBV Technologies S.A.'s fiscal year end?

DBV Technologies S.A.'s fiscal year ends on December 31.

How much revenue did DBV Technologies S.A. report?

DBV Technologies S.A. reported $5.6M in revenue for calendar year 2025, according to its SEC filings.